SENISCA awarded Innovate UK grant to develop oligonucleotide therapeutics for the treatment of idiopathic pulmonary fibrosis (IPF). Exeter, UK – 20 April 2023: SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and target the diseases of ageing, today announces that it has been...

Exeter Hospital joins North American Partners in Anesthesia MELVILLE, N.Y., Dec. 03, 2018 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA), one of the leading single-specialty anesthesia and perioperative management companies in the US,...

PATH Releases Recommendations To Phillips Exeter Academy Regarding Sexual Misconduct BOSTON, Sept. 26, 2018 (GLOBE NEWSWIRE) -- PATH (Phillips Exeter Alumni for Truth and Healing) today announced it has released a petition with specific recommendations for Phillips Exeter Academy to...

Inaugural Ambius Twitter Chat Set for December 1st at 8 p.m. ET/1 a.m. GMT BUFFALO GROVE, IL--(Marketwire - November 8, 2010) -  Ambius, www.ambius.com, the premier global creator of ambience for businesses, announces their first global Twitter chat on December 1st,...